Quest Diagnostics (DGX) news
Recent news
Quest Diagnostics Inc: Leerink partners raises target price to $265 from $254
Leerink Partners has raised its price target for Quest Diagnostics Inc. (DGX) to $265 from $254, reflecting the firm’s updated outlook for the diagnostic services provider. The adjustment follows a series of positive developments, including Quest’s recent expansion into precision psychiatry through…
AInvest Wire · 6d agoQuest Diagnostics falls 7.2%; LabCorp shares drop 5.5%
AInvest Wire · Sep 22, 2026Quest Diagnostics: Buy & schedule tests for $119
Quest Diagnostics, a leading provider of diagnostic testing services, has introduced a new offering that allows customers to purchase and schedule a range of tests for a flat fee of $119. This initiative is part of the company’s broader strategy to increase accessibility to diagnostic services…
AInvest Wire · Sep 9, 2026Apple Health users in US to be able to order labs from Quest
Apple Health users in the United States will soon be able to order laboratory tests directly through Quest Diagnostics, expanding the integration between the Apple Health platform and diagnostic services. This development follows Quest’s ongoing efforts to enhance digital health tools for patients,…
AInvest Wire · Sep 9, 2026Quest Diagnostics Inc: UBS raises target price to $245 from $232
AInvest Wire · Sep 8, 2026Light Horse does not author, endorse or verify the headlines, and their appearance here is not an endorsement of any view they express.
This page is for informational purposes only. Nothing on it is a recommendation, solicitation or offer to buy or sell any security, nor investment, legal or tax advice. Light Horse Securities Inc does not verify third-party data and is not responsible for its accuracy, completeness or timeliness.